Skip to main content
Signal8

Domzalski David

SEC insider (Form 3/4/5 filer). CIK 0001727794. PRESIDENT AND CEO at VYNE Therapeutics Inc. (VYNE). 13 reported Form 4/5 transactions since Sep 2024; latest on Jul 23, 2026. Located in STEWARTSVILLE, NJ.

Companies Domzalski David has filed insider reports for

  • VYNE Therapeutics Inc. (VYNE): Director, Officer, PRESIDENT AND CEO
Domzalski David profile photo

Domzalski David

CIK: 0001727794

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (30.8%)

Compensation grants

Other (G, F, J, C, D, …)9 (69.2%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VYNE Therapeutics Inc. logo
VYNE

VYNE Therapeutics Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (13 total)

  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Jul 23, 2026
    Tax Payment
    Direct
    79.4K shares at avg. $0.90$71K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Jun 30, 2026
    Tax Payment
    Direct
    12.2K shares at avg. $0.65$8K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    May 29, 2026
    Award
    Direct
    30.8K shares at avg. $0.31$10K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Mar 31, 2026
    Tax Payment
    Direct
    14.2K shares at avg. $0.60$9K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Dec 31, 2025
    Tax Payment
    Direct
    12.7K shares at avg. $0.58$7K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Sep 30, 2025
    Tax Payment
    Direct
    12.7K shares at avg. $0.34$4K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Jun 30, 2025
    Tax Payment
    Direct
    12.7K shares at avg. $1.65$21K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Jun 2, 2025
    Award
    Direct
    8.7K shares at avg. $0.81$7K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Mar 31, 2025
    Tax Payment
    Direct
    30.5K shares at avg. $1.58$48K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Jan 21, 2025
    Award

    Stock Option (right to buy)

    Direct
    730K shares-

1-10 of 13